Elizabeth A. Duncan M.D.

Elizabeth A. Duncan MD PhD is an experienced clinical development leader currently serving as Senior Director of Clinical Development Research at GSK since May 2024. Previously, Elizabeth held roles including Clinical Program Lead at Chiesi Group and Global Clinical Head at AstraZeneca, where responsibilities included leading clinical strategies for drugs targeting asthma, COPD, and inflammatory bowel diseases. Elizabeth's extensive background also includes positions as Group Director and Senior Medical Lead at AstraZeneca, focusing on clinical trial oversight and regulatory interactions. Elizabeth's academic roles have included Adjunct Assistant Professor at the University of North Carolina at Chapel Hill. Educational qualifications consist of a MD, PhD from UT Southwestern Medical Center, and advanced medical training in Allergy and Immunology from the University of North Carolina at Chapel Hill.